VitreoRetinal Associates

Gainesville, Florida 34481

7 studies enrolling now · 21 studies all time

What they study most

ARB, Achromatopsia, Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Autosomal Dominant Retinitis Pigmentosa, Autosomal-Dominant Bestrophinopathy, BVMD, Best Vitelliform Macular Dystrophy, Choroidal Neovascularization, Cone Rod Dystrophy, Diabetic Macular Edema, Eye Diseases

Studies at this site

• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) — Recruiting now
• Study of ALK-001 on the Progression of Stargardt Disease — Recruiting now
• Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) — Recruiting now
• Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) — Recruiting now
• 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration — Recruiting now
• Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) — Recruiting now
• An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene — Recruiting now
• Rate of Progression in EYS Related Retinal Degeneration — Completed
• Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP) — Running, not enrolling
• Rate of Progression in USH2A-related Retinal Degeneration — Running, not enrolling
• Oral N-acetylcysteine for Retinitis Pigmentosa — Running, not enrolling
• 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) — Running, not enrolling
• A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
• Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGB3 Achromatopsia (A Clarity Clinical Trial) — Status unconfirmed
• Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial) — Running, not enrolling
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene — Running, not enrolling
• Clinical and Genetic Characterization of Individuals With Achromatopsia — Completed